Affiliation:
1. Xiyuan Hospital
2. Beijing University of Chinese Medicine
3. Guangdong Provincial Hospital of Traditional Chinese Medicine
Abstract
Abstract
Objective
To evaluate Chinese cancer patients’ health related quality of life and its predictor factors during the COVID-19 pandemic.
Method
We conducted an online cross-sectional survey study among Chinese cancer patients in 2020 around China by utilizing the validated Mandarin version of COVID-19 IHRQOL questionnaire.
Results
387 patients participated in this survey, in which 283(72.9%) patients worried the pandemic’s impact on their cancer care, 69% feared getting infected by COVID-19. 30.7% and 17.3% patients had experienced depression and social isolation. More than 80% patients reported perceived benefits such as feeling more grateful. 26.3% patients reported financial hardship and 44.9% reported cancer care disruption. Multivariate analyses showed that more financial hardship was significantly associated with higher level of COVID-19 specific distress (p < 0.001).
Conclusion
Addressing health care services disruption and financial hardship, as well as promoting functional social support might help Chinese cancer patients acquire better HRQoL during the pandemic.
Publisher
Research Square Platform LLC
Reference38 articles.
1. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis;Lancet,2022
2. Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy;Joshi G;Hum Vaccin Immunother,2022
3. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study;Yang K;Lancet Oncol,2020
4. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China;Liang W;Lancet Oncol,2020
5. The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016–2020;Xiao H;Lancet Reg Health West Pac,2021